Get started
Author

Aleksander Salomon‐Perzyński

Observed names: A. Salomon-Perzyński, Aleksander Perzyński, Aleksander Salomon Perzyński, Aleksander Salomon-Perzynski, Aleksander Salomon-Perzyński, Aleksander Salomon‑Perzyński
ORCID: 0000-0002-8394-5346
Observed ORCID: 0000-0002-8394-5346
OpenAlex ID: A5017433276
High-grade serous ovarian cancer: the clone wars
2017 · Aleksander Salomon-Perzyński, Magdalena Salomon-Perzyńska, et al. · Archives of Gynecology and Obstetrics · 45
PDF
CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma
2022 · Joanna Barankiewicz, Aleksander Salomon-Perzyński, et al. · Cancers · 39
PDF
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
2021 · Artur Jurczyszyn, Jorge J. Castillo, et al. · Clinical Lymphoma Myeloma & Leukemia · 29
PDF
Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
2021 · Aleksander Salomon-Perzyński, Krzysztof Jamroziak, et al. · Diagnostics · 26
PDF
Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma
2019 · Aleksander Salomon-Perzyński, Adam Walter-Croneck, et al. · Advances in Medical Sciences · 26
Immunochemotherapy for Richter syndrome: current insights
2019 · Bartosz Puła, Aleksander Salomon-Perzyński, et al. · ImmunoTargets and Therapy · 17
PDF
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model
2022 · Olga Sokolowska, Anna Rodziewicz-Lurzynska, et al. · Clinical and Experimental Medicine · 16
PDF
A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia
2022 · Agnieszka Goral, Malgorzata Firczuk, et al. · Frontiers in Immunology · 14
PDF
The management of hematologic malignancies during the COVID-19 pandemic
2020 · Iwona Hus, Aleksander Salomon-Perzyński, et al. · Expert Opinion on Pharmacotherapy · 14
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
2021 · Bożena Katarzyna Budziszewska, Aleksander Salomon-Perzyński, et al. · Cancers · 13
PDF
Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
2022 · Aleksander Salomon-Perzyński, Joanna Barankiewicz, et al. · Biomedicines · 10
PDF
VEGF – targeted therapy for the treatment of cervical cancer – literature review
2014 · Magdalena Salomon-Pierzyńska, Beata Rembielak-Stawecka, et al. · Ginekologia Polska · 10
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group
2019 · Iwona Hus, Joanna Mańko, et al. · Oncology Letters · 9
PDF
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
2021 · Joanna Barankiewicz, Anna Szumera-Ciećkiewicz, et al. · Journal of Clinical Medicine · 8
PDF
The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of multiple myeloma patients
2020 · Aleksander Salomon-Perzyński, Aleksandra Bluszcz, et al. · Polskie Archiwum Medycyny Wewnętrznej · 8
PDF
The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia
2020 · Iwona Hus, Aleksander Salomon-Perzyński, et al. · Expert Opinion on Biological Therapy · 6
Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors
2024 · Filip Garbicz, Marcin Kaszkowiak, et al. · International Journal of Molecular Sciences · 4
PDF
PIM Kinase Inhibition Decreases the Proangiogenic Properties of Multiple Myeloma Cells and Affects the Metabolic State of the Vascular Endothelium
2020 · Filip Garbicz, Anna Szumera-Ciećkiewicz, et al. · Blood · 3
Doksycyklina w terapii amyloidozy układowej z zajęciem serca
2018 · Justyna Łyczkowska-Piotrowska, Aleksander Salomon-Perzyński, et al. · Hematologia · 3
PDF
Safe administration of rituximab in patients with chronic lymphocytic leukemia and a history of obinutuzumab‑associated anaphylaxis
2018 · Aleksander Salomon‑Perzyński, Agnieszka Końska, et al. · Polskie Archiwum Medycyny Wewnętrznej · 3
PDF
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors
2020 · Bartosz Puła, Monika Długosz-Danecka, et al. · Advances in Medical Sciences · 2
PDF
Jak leczymy pacjenta z nowo rozpoznaną amyloidozą łańcuchów lekkich pośredniego ryzyka? Rola doksycykliny w terapii amyloidozy z zajęciem serca
2018 · Aleksander Salomon-Perzyński, Agnieszka Końska, et al. · Hematologia · 2
PDF
Rola daratumumabu w leczeniu chorych na nawrotowego i opornego szpiczaka plazmocytowego
2018 · Aleksander Salomon Perzyński, Krzysztof Jamroziak · Hematologia · 2
PDF
How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?
2023 · Aleksander Salomon-Perzyński, Bożena Katarzyna Budziszewska · Hematology in Clinical Practice · 1
PDF
Super-Enhancer-Driven PIM Kinase Upregulation in Multiple Myeloma Maintains the Plasma Cell-Specific Oncogenic and Microenvironmental Circuits, and Can be Efficiently Targeted By the Pan-PIM Inhibitor MEN1703
2022 · Filip Garbicz, Sonia Debek, et al. · Blood · 1
Works count: 30
Citation count: 314
H-index: 10
I10-index: 12
Year
Topic
Type